The G i -coupled, ADP-activated P2Y 12 receptor is well characterized as playing a key role in platelet activation via crosstalk with the P2Y 1 
Introduction
The adenine nucleotide ADP serves as an important signalling molecule that is implicated in processes such as platelet aggregation (Dorsam and Kunapuli, 2004) and immune modulation (Ben Addi et al., 2010) . ADP binds to P2Y 1 , P2Y 6 , P2Y 12 and P2Y 13 receptors, which are members of the G protein-coupled P2Y receptor family. Activation of G qcoupled P2Y 1 and P2Y 6 receptors causes downstream inositol 1,4,5-triphosphate (IP 3 ) generation via PLC-mediated breakdown of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) and subsequent calcium ion (Ca 2+ ) release through endoplasmic reticulum IP 3 receptors (Erb and Weisman, 2012) . Conversely, P2Y 12 and P2Y 13 receptors are G i -coupled and hence inhibit production of cAMP and stimulate PI3K when activated (Erb and Weisman, 2012) . Platelet aggregation in response to ADP is one of the earliest examples of extracellular nucleotide signalling. It is firmly established that ADP activates platelets via the P2Y 1 and P2Y 12 receptors, and the functionality of both receptors is required for normal platelet aggregation (Jin and Kunapuli, 1998) . The emergence of the P2Y 12 receptor as a vital component in ADP-evoked platelet activation has led to the development of anti-platelet drugs targeting this receptor, such as ticagrelor and clopidogrel. The rise in cytosolic Ca 2+ in response to ADP is deemed responsible for the ADP-mediated activation of platelets (Dorsam and Kunapuli, 2004) . Although the P2Y 12 receptor is G i -coupled and should therefore not cause intracellular Ca 2+ mobilization, outcomes from a previous study suggest that the P2Y 12 receptor potentiates the G q P2Y 1 receptor-mediated Ca 2+ response to ADP in a crosstalk mechanism (Hardy et al., 2004) . Hardy et al. (2004) proposed that P2Y 12 receptors mediate inhibition of adenylate cyclase and activation of PI3K, which collectively positively modulates the Ca 2+ signal induced by ADP. The same P2Y 1 -P2Y 12 crosstalk mechanism described in platelets by Hardy et al. (2004) was also suggested to be present in glioma C6 cells (Suplat et al., 2007) . The role of P2Y 12 receptors in cells other than platelets is not well described, although recent evidence is promising. Findings by West et al. (2014) indicate a role for vessel wall P2Y 12 receptors in early atherogenesis, rather than platelet P2Y 12 receptors. In addition to cardiovascular disease, the P2Y 12 receptors has potentially been implicated in immune responses to ADP in macrophages (Zhang et al., 2018) and dendritic cells (Ben Addi et al., 2010) in functions such as antigen uptake and chemotaxis. Therefore, non-platelet roles for P2Y 12 receptors have been suggested and should be further investigated.
Monocytes are essential immune cells that, together with their progeny, facilitate innate immune defence via phagocytosis and cytokine production, but also activate the adaptive immune system through antigen uptake and presentation (Ziegler-Heitbrock, 2006 
RNA extraction and RT-PCR
Total RNA was extracted from THP-1 cells and CD14 + monocytes using Tri reagent (Sigma Aldrich, Haverhill, UK) with a subsequent DNase I treatment (Ambion). Complementary DNA was synthesized from 1 μg of total RNA using Superscript II reverse transcriptase (Invitrogen, Waltham, USA). PCR was performed using a Taq polymerase readymix (Sigma Aldrich, Haverhill, UK) using primer pairs designed using the following sequences (accession numbers): P2RY1 -GTTCAA ) BSA and incubated with cells overnight a 4°C and for 1 h at room temperature respectively. Cells were mounted in Vectashield containing nucleus counterstain (DAPI). Goat polyclonal anti-P2Y 12 (Santa Cruz Biotechnology, Texas, USA) was used with Alexa 488-conjugated rabbit antigoat (Abcam, Cambridge, UK). Rabbit polyclonal anti-P2Y 1 , anti-P2Y 6 and anti-P2Y 13 (Alomone, Jerusalem, Israel) were used with Alexa 488-conjugated goat anti-rabbit (Invitrogen, Waltham, USA). Cell imaging was performed using a laser-scanning Zeiss LSM510 Meta confocal microscope.
Transmigration assays
Transwell migration assay was performed as previously described (Sivaramakrishnan et al., 2012; Campwala et al., 2014) . Briefly, assays were performed in 24-well plates using polyethylene terephthalate membrane transwell inserts with 3 μm pores. THP-1 cells, 1 × 10 6 in RPMI (no serum) with vehicle or drug treatment were added to the upper chamber, and 3 μM ADP or vehicle added to the lower chamber. Assays were performed for 2 h at 37°C, and migrated cells counted on the underside of the transwell support using crystal violet staining. Chemotaxic index was calculated as the ratio of cells that migrated to ADP over vehicle control.
Data analysis
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Data analysis was performed using Origin Pro 9.0 software (Origin Lab, USA). Dose-response curves were fitted assuming a Hill coefficient of 1, with the Hill equation used to determine the degree of ligand-receptor cooperation. Figure data points represent mean values ± SEM (error bars). Statistical significance was determined using Student's paired t-tests. Each point in the dose-response plots represents the average of the peak Ca 2+ response. A confidence interval of 5% (P < 0.05) is used throughout for statement of significance. Dose-response relationships were fitted using the Hill equation:
where n H represents the Hill slope.
Chemicals and reagents
Unless otherwise stated, all chemicals and reagents were purchased from Sigma-Aldrich (Haverhill, UK), with the exception of pertussis toxin and SQ22536 (Tocris, Bristol, UK 
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a,b) .
Results
ADP-evoked intracellular Ca 2+ responses are mediated by P2Y 6 receptor activation and modulated by G i -dependent signalling ADP evoked concentration-dependent increases in intracellular Ca 2+ with an EC 50 of 2.7 ± 0.3 μM (n = 5) ( Figure 1A , B).
Responses to maximal ADP concentrations were abolished following either PLC inhibitor treatment (U73122) ( Figure 1C Figure S1 ). P2Y 6 antagonism by MRS2578 inhibited the ADP response almost completely with an EC 50 of 200 ± 20 nM (n = 3) ( Figure 1E, F) . MRS2578 inhibited the ADP response in a noncompetitive fashion ( Figure 1G ), consistent with the reported mode of antagonism at P2Y 6 receptors (Mamedova et al., 2004) and with previous findings (Sivaramakrishnan et al., 2012; Campwala et al., 2014) . Selective inhibition of P2Y 1 receptors with MRS2500 (tested up to 10 μM) ( Figure 1H ) or P2Y 13 receptors with MRS2211 (tested up to 10 μM) ( Figure 1I ) had no significant effect on ADP-evoked Ca responses. In addition to a dependence on PLC activity and release of ER Ca 2+ stores, we investigated the effect of G idependent signalling by using Bordetella pertussis toxin (PTx). PTx treatment (5 nM, 3 h) caused a significant attenuation of ADP-evoked intracellular Ca 2+ responses (Figure 2A ), significantly suppressing the maximal response by approximately 30% and the EC 50 for ADP (EC 50 1.9 ± 0.3 μM vs. 2.9 ± 0.2 μM with PTx; P < 0.05, n = 5) ( Figure 2B ). In control experiments, CCL2-evoked Ca For all experiments, F ratio is the ratiometric measurement of intracellular Ca 2+ using fura-2. *P < 0.05.
We next determined the expression of ADP receptors in THP-1 cells in an effort to probe further the molecular basis of ADP-evoked Ca 2+ responses and identify receptors that may modulate them. RT-PCR analysis of P2Y receptors activated by ADP (Communi et al., 1996; Erb and Weisman, 2012) in THP-1 cells revealed the expression of P2Y 1 , P2Y 6 , P2Y 12 and P2Y 13 receptors ( Figure 3A ). P2Y 12 receptor mRNA expression was confirmed in freshly isolated CD14 + monocytes ( Figure 3B ). P2Y 1 , P2Y 6 , P2Y 12 and P2Y 13 receptor protein expression was confirmed by immunocytochemistry and confocal microscopy ( Figure 3C ).
Effect of P2Y 12 receptor antagonism and knockdown on ADP-evoked Ca 2+ responses in THP-1 cells
Of the ADP receptors expressed by THP-1 monocytes, the P2Y 12 receptor is a known G i -coupled receptor. The role of P2Y 12 receptor activation during ADP challenge was investigated using PSB-0739, a high affinity competitive antagonist (Baqi et al., 2009) , and ticagrelor, a P2Y 12 antagonist used clinically as an anti-thrombotic agent (Husted et al., 2006) . Ticagrelor inhibited ADP-evoked Ca 2+ responses in THP-1 cells in a concentration-dependent fashion ( Figure 4A ).
Ticagrelor inhibited ADP-evoked Ca 2+ responses with an EC 50 of 4.7 ± 1.8 μM (n = 5) and a non-competitive mode of action ( Figure 4B, C) . This is consistent with the observations of van Giezen et al. (2009) where ticagrelor binds to P2Y 12 at a site distinct from that of ADP, producing a non-competitive inhibition of ADP-induced aggregation in human platelets. PSB-0739 inhibited ADP-evoked Ca 2+ responses with an EC 50 of 5.4 ± 1.8 μM (n = 5) ( Figure 4D , E) and caused a rightward parallel shift in the ADP concentration-response curve ( Figure 4F ). Inhibition of the ADP response was approximately 80% at the highest concentrations of PSB-0739 tested. Several studies have suggested that ticagrelor produces cardiovascular benefit through a pleiotropic inhibition of the equilibrative nucleoside transporter 1 (ENT-1) (Aungraheeta et al., 2016) , and a consequent elevation in extracellular adenosine. To rule out this mechanism of action in THP-1 cells, we inhibited ENT-1 using 3 μM 6-S-[(4-nitrophenyl)methyl]-6-thioinosine (NBMPR), but observed no effect on ADP-evoked Ca 2+ responses (data not shown Figure 4G , H). To investigate the biological relevance of P2Y 12 receptor inhibition in THP-1 cells, we assayed transmigration in response to ADP. In these experiments, ADP stimulated significant THP-1 cell transmigration over a 2 h period compared to vehicle ( Figure 4I ). The addition of either ticagrelor or PSB-0739 attenuated cell migration to ADP ( Figure 4I ). Together, these data reveal that P2Y 12 receptor activity is functionally important for the generation of ADP-evoked intracellular Ca 2+ responses and migration in THP-1 cells.
Adenylate cyclase inhibition reverses antagonistic effect of ticagrelor
We hypothesized that the molecular mechanism underlying the positive contribution of the P2Y 12 receptor to ADPevoked Ca 2+ responses could be due to a number of possibili- Chemotactic indexes comparing cell movement over 2 h in control conditions (vehicle), 3 μM ADP alone or in the presence of either ticagrelor (3 μM) or PSB-0739 (25 μM) (*P < 0.05 vs. ADP alone; n = 5).
the requirement of adenylate cyclase activity for mediating the inhibitory action of ticagrelor. Adenylate cyclase inhibition with 300 μM SQ22536 had no effect on ADP-evoked Ca 2+ responses ( Figure 5A ). However, SQ22536 could reverse the effect of ticagrelor, restoring the ADP concentration-response relationship and maximum response (F max = 3.32 ± 0.26 for ADP + 5 μM ticagrelor + 300 μM SQ22536; F max = 2.64 ± 0.21, ADP + 5 μM ticagrelor; F max = 1.06 ± 0.10; n = 5. The F max for ADP + 5 μM ticagrelor vs. ADP + vehicle control is significantly different, P < 0.05) ( Figure 5B, C) .
Discussion
In this study, we demonstrated novel findings identifying a role for P2Y 12 receptors in regulating intracellular Ca 2+ signalling in non-platelet cells. We utilized THP-1 cells, a model used extensively to investigate human monocyte function, to demonstrate a functional role for the P2Y 12 receptor. In addition, we identified P2Y 12 receptor expression in human CD14 + monocytes. There have been no published reports on the expression of P2Y 12 receptors in monocytes thus far; however, the involvement of P2Y 12 receptors in the function of macrophages was investigated by Kronlage et al. (2010) . Stimulation of P2Y 12 receptors in macrophages was found to induce cell spreading with formation of lamellipodia and inhibition of multiple purine receptors, including P2Y 12 , attenuated chemotaxis (Kronlage et al., 2010) . The signal transduction mechanisms downstream of the P2Y 12 receptor were not investigated in this study. P2Y 12 receptor expression has also been reported in glial cells, smooth muscle and endothelium (Cattaneo, 2007) .
In this study, we demonstrated that ADP evokes intracellular Ca 2+ signalling via P2Y 6 receptor activation. The P2Y 6 receptor is often considered as the metabotropic receptor for uridine diphosphate (UDP). Although UDP is a more potent agonist at the human P2Y 6 receptor by several orders of magnitude, ADP is a full agonist with a half-maximal concentration for IP 3 production in the micromolar range (Communi et al., 1996) . ADP is an important signalling cue in monocyte/macrophage biology. For example, in the same cell-line used in this investigation, THP-1, ADP stimulation caused release of the cytokine TNF-α (Mattana et al., 2002) . TNF-α release causes an inflammatory innate immune response including immune cell recruitment. In addition, ADP has been shown in this investigation to induce calcium signals in THP-1 cells, and calcium signalling in circulating monocytes has in fact been suggested to result in the development of mature dendritic cells (Czerniecki et al., 1997) . Such examples indicate that ADP contributes to monocyte function, with specific reference to immune responses and differentiation. ADP released from Escherichia coli-infected mice, and from macrophages exposed to LPS, protected mice from E. coli-induced peritonitis via macrophage recruitment (Zhang et al., 2018) . Additionally, ADP caused production of CCL2, a crucial chemokine in immune cell recruitment, which accordingly attracted more macrophages in a transwell assay (Zhang et al., 2018) . Inhibition of downstream P2Y 12 receptor signalling, or macrophage P2Y 12 receptor deficiency, blocked immune responses to ADP, in turn allowing more bacteria to persist in infected mice (Zhang et al., 2018 For all experiments, F ratio is the ratiometric measurement of intracellular Ca 2+ using fura-2. *P < 0.05. (Communi et al., 1997) have highlighted promiscuity for G s -and G q -coupling by P2Y 11 receptors that is expressed by THP-1 cells (unpublished data). However, the P2Y 11 receptor is activated by ATP not by ADP at concentrations used in this study (Communi et al., 1997) . How might the P2Y 12 receptor regulate P2Y 6 receptordependent signalling via adenylate cyclase? Firstly, this is unlikely to involve PKA-dependent phosphorylation of the P2Y 6 receptor or receptor desensitization. Compared with other P2Y receptors, such as P2Y 4 , the P2Y 6 receptor displays limited reduction in cell surface number even in the presence of maximal agonist concentrations (Brinson and Harden, 2000) . There are no consensus PKA phosphorylation sites in the cytoplasmic loops of P2Y 6 , receptors, although this cannot discount the possibility of PKA phosphorylation of an auxiliary protein that positively regulates P2Y 6 receptor activity.
There is currently much interest in the biological effects of P2Y 12 antagonists beyond platelets (Nylander and Schulz, 2016) . Although further work is required to investigate the role of the P2Y 12 receptor in freshly isolated human monocytes, this work suggests that physiological and pharmacological modulation of P2Y 12 receptors can influence ADP-evoked intracellular Ca 2+ signalling in THP-1 cells and perhaps monocytes, which will likely influence key monocyte functions such as migration, adhesion and cytokine production.
